MYD88 and coronary artery disorder: Toll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88), which act as the gate of the innate immune system and the trigger of the adaptive immune system, have been extensively studied for their roles in the pathogenesis and progression of CAD [6,7].